|
|
|
Discourse is an open-source discussion platform. Prior to version 3.1.0.beta3 of the `beta` and `tests-passed` branches, attackers are able to bypass Discourse's server-side request forgery (SSRF) protection for private IPv4 addresses by using a IPv4-mapped IPv6 address. The issue is patched in the latest beta and tests-passed version of Discourse. version 3.1.0.beta3 of the `beta` and `tests-passed` branches. There are no known workarounds.
Publish Date : 2023-03-17 Last Update Date : 2023-03-23
-
CVSS Scores & Vulnerability Types
| CVSS Score |
0.0 |
| Confidentiality Impact |
??? |
| Integrity Impact |
??? |
| Availability Impact |
??? |
| Access Complexity |
??? |
| Authentication |
??? |
| Gained Access |
None |
| Vulnerability Type(s) |
Bypass a restriction or similar |
| CWE ID |
918 |
|
|
-
Products Affected By CVE-2023-28111
-
Number Of Affected Versions By Product
-
References For CVE-2023-28111
|
|
-
Metasploit Modules Related To CVE-2023-28111
|
|
|
|
CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is
MITRE's CVE web site.
CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is
MITRE's CWE web site.
OVAL is a registered trademark of The MITRE Corporation and the authoritative source of OVAL content is
MITRE's OVAL web site.
Use of this information constitutes acceptance for use in an AS IS condition.
There are NO warranties, implied or otherwise, with regard to this information or its use.
Any use of this information is at the user's risk.
It is the responsibility of user to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content.
EACH USER WILL BE SOLELY RESPONSIBLE FOR ANY consequences of his or her direct or indirect use of this web site.
ALL WARRANTIES OF ANY KIND ARE EXPRESSLY DISCLAIMED. This site will NOT BE LIABLE FOR ANY DIRECT,
INDIRECT or any other kind of loss.
